{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:58:06Z","timestamp":1793404686870,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"CAMS Innovation Fund for Medical Sciences","award":["2024-I2M-C&T-B-034"],"award-info":[{"award-number":["2024-I2M-C&T-B-034"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0509500"],"award-info":[{"award-number":["2023ZD0509500"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-C-069"],"award-info":[{"award-number":["2022-PUMCH-C-069"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04381-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T04:14:44Z","timestamp":1780028084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["68Ga-FAPI PET\/CT features of thoracic sarcoidosis: a prospective observational study"],"prefix":"10.1186","volume":"26","author":[{"given":"Ruxuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"11","key":"4381_CR1","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and Its Management. N Engl J Med. 2021;385(11):1018\u201332.","journal-title":"N Engl J Med"},{"issue":"9","key":"4381_CR2","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2022.1570","volume":"327","author":"JA Belperio","year":"2022","unstructured":"Belperio JA, Shaikh F, Abtin FG, Fishbein MC, Weigt SS, Saggar R, et al. Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review. JAMA. 2022;327(9):856\u201367.","journal-title":"JAMA"},{"key":"4381_CR3","doi-asserted-by":"publisher","first-page":"1558049","DOI":"10.3389\/fmed.2025.1558049","volume":"12","author":"YM Waly","year":"2025","unstructured":"Waly YM, Sharafeldin AK, Akhtar MU, Chilmeran Z, Fredericks S. A review of sarcoidosis etiology, diagnosis and treatment. Front Med (Lausanne). 2025;12:1558049.","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"4381_CR4","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00259-024-06915-3","volume":"52","author":"G Abikhzer","year":"2025","unstructured":"Abikhzer G, Treglia G, Pelletier-Galarneau M, Buscombe J, Chiti A, Dibble EH, et al. EANM\/SNMMI guideline\/procedure standard for [(18)F]FDG hybrid PET use in infection and inflammation in adults v2.0. Eur J Nucl Med Mol Imaging. 2025;52(2):510\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"4381_CR5","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","volume":"53","author":"M Bentestuen","year":"2023","unstructured":"Bentestuen M, Al-Obaydi N, Zacho HD. FAPI-avid nonmalignant PET\/CT findings: An expedited systematic review. Semin Nucl Med. 2023;53(5):694\u2013705.","journal-title":"Semin Nucl Med"},{"key":"4381_CR6","doi-asserted-by":"crossref","unstructured":"Chandekar KR, Prashanth A, Vinjamuri S, Kumar R. FAPI PET\/CT Imaging-An Updated Review. Diagnostics (Basel). 2023;13(12):2018.","DOI":"10.3390\/diagnostics13122018"},{"issue":"6","key":"4381_CR7","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W, et al. (68)Ga-FAPI PET\/CT: Tracer Uptake in 28 Different Kinds of Cancer. J Nucl Med. 2019;60(6):801\u20135.","journal-title":"J Nucl Med"},{"issue":"11","key":"4381_CR8","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1136\/annrheumdis-2020-217408","volume":"79","author":"C Schmidkonz","year":"2020","unstructured":"Schmidkonz C, Rauber S, Atzinger A, Agarwal R, Gotz TI, Soare A, et al. Disentangling inflammatory from fibrotic disease activity by fibroblast activation protein imaging. Ann Rheum Dis. 2020;79(11):1485\u201391.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4381_CR9","doi-asserted-by":"publisher","first-page":"e185","DOI":"10.1016\/S2665-9913(20)30421-5","volume":"3","author":"C Bergmann","year":"2021","unstructured":"Bergmann C, Distler JHW, Treutlein C, Tascilar K, Muller AT, Atzinger A, et al. (68)Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study. Lancet Rheumatol. 2021;3(3):e185\u201394.","journal-title":"Lancet Rheumatol"},{"issue":"2","key":"4381_CR10","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1164\/rccm.202110-2414OC","volume":"207","author":"P Yang","year":"2023","unstructured":"Yang P, Luo Q, Wang X, Fang Q, Fu Z, Li J, et al. Comprehensive Analysis of Fibroblast Activation Protein Expression in Interstitial Lung Diseases. Am J Respir Crit Care Med. 2023;207(2):160\u201372.","journal-title":"Am J Respir Crit Care Med"},{"key":"4381_CR11","doi-asserted-by":"publisher","first-page":"103471","DOI":"10.1016\/j.jaut.2025.103471","volume":"156","author":"K Kastrati","year":"2025","unstructured":"Kastrati K, Pochepnia S, Kulterer OC, Nakuz TS, Mrak D, Gessl I, et al. FAPI PET\/CT for tracking disease trajectory in myositis-related interstitial lung disease. J Autoimmun. 2025;156:103471.","journal-title":"J Autoimmun"},{"issue":"4","key":"4381_CR12","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0738-081X(86)90031-3","volume":"4","author":"AG Arnoux","year":"1986","unstructured":"Arnoux AG, Reynolds HY. Granuloma formation and fibrosis in sarcoidosis. Clin Dermatol. 1986;4(4):22\u201334.","journal-title":"Clin Dermatol"},{"issue":"8","key":"4381_CR13","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):e26\u201351.","journal-title":"Am J Respir Crit Care Med"},{"key":"4381_CR14","doi-asserted-by":"crossref","unstructured":"Baughman RP, Valeyre D, Korsten P, Mathioudakis AG, Wuyts WA, Wells A et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir J. 2021;58(6) :2004079.","DOI":"10.1183\/13993003.04079-2020"},{"issue":"9","key":"4381_CR15","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","volume":"59","author":"T Lindner","year":"2018","unstructured":"Lindner T, Loktev A, Altmann A, Giesel F, Kratochwil C, Debus J, et al. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. J Nucl Med. 2018;59(9):1415\u201322.","journal-title":"J Nucl Med"},{"issue":"9","key":"4381_CR16","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1470-2045(25)00299-2","volume":"26","author":"KM Pabst","year":"2025","unstructured":"Pabst KM, Weber MM, Laschinsky C, Sandach P, Bartel T, Kuper AT, et al. [(68)Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial. Lancet Oncol. 2025;26(9):1204\u201314.","journal-title":"Lancet Oncol"},{"issue":"1","key":"4381_CR17","doi-asserted-by":"publisher","first-page":"ytac005","DOI":"10.1093\/ehjcr\/ytac005","volume":"6","author":"J Siebermair","year":"2022","unstructured":"Siebermair J, Kessler L, Kupusovic J, Rassaf T, Rischpler C. Cardiac fibroblast activation detected by (68)Gallium-FAPI-46 positron emission tomography-magnetic resonance imaging as a sign of chronic activity in cardiac sarcoidosis. Eur Heart J Case Rep. 2022;6(1):ytac005.","journal-title":"Eur Heart J Case Rep"},{"issue":"9","key":"4381_CR18","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1007\/s00259-023-06236-x","volume":"50","author":"Y Pang","year":"2023","unstructured":"Pang Y, Wang P, Xu W, Zhao L, Chen H. Identification of isolated hepatic sarcoidosis with [(18)F]FDG and [(68) Ga]Ga-FAPI PET\/CT. Eur J Nucl Med Mol Imaging. 2023;50(9):2918\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"8","key":"4381_CR19","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1093\/qjmed\/hcae067","volume":"117","author":"S O\u2019Brien","year":"2024","unstructured":"O\u2019Brien S, Musameh K, El Obeid M, Butler T, Armstrong M, Cunningham Z, et al. Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET\/CT. QJM. 2024;117(8):603\u20134.","journal-title":"QJM"},{"issue":"4","key":"4381_CR20","doi-asserted-by":"publisher","first-page":"634","DOI":"10.2967\/jnumed.124.268943","volume":"66","author":"S Liu","year":"2025","unstructured":"Liu S, Pan Q, Zhang H, Peng L, Zhang W, Feng Y, et al. Differences in Fibroinflammatory Activity Shown on (68)Ga-FAPI-04 and (18)F-FDG PET\/CT in the Two Subtypes of IgG4-Related Disease. J Nucl Med. 2025;66(4):634\u201340.","journal-title":"J Nucl Med"},{"issue":"11","key":"4381_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/RLU.0000000000003279","volume":"45","author":"B Gu","year":"2020","unstructured":"Gu B, Luo Z, He X, Wang J, Song S. 68Ga-FAPI and 18F-FDG PET\/CT Images in a Patient With Extrapulmonary Tuberculosis Mimicking Malignant Tumor. Clin Nucl Med. 2020;45(11):865\u20137.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"4381_CR22","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1007\/s00259-023-06564-y","volume":"51","author":"Y Mori","year":"2024","unstructured":"Mori Y, Kramer V, Novruzov E, Mamlins E, Rohrich M, Fernandez R, et al. Initial results with [(18)F]FAPI-74 PET\/CT in idiopathic pulmonary fibrosis. Eur J Nucl Med Mol Imaging. 2024;51(6):1605\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"4381_CR23","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1148\/rg.2018180053","volume":"38","author":"G Akaike","year":"2018","unstructured":"Akaike G, Itani M, Shah H, Ahuja J, Yilmaz Gunes B, Assaker R, et al. PET\/CT in the Diagnosis and Workup of Sarcoidosis: Focus on Atypical Manifestations. Radiographics. 2018;38(5):1536\u201349.","journal-title":"Radiographics"},{"issue":"4","key":"4381_CR24","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1007\/s00330-024-10949-4","volume":"35","author":"R Donnelly","year":"2025","unstructured":"Donnelly R, McDermott M, McManus G, Franciosi AN, Keane MP, McGrath EE, et al. Meta-analysis of [(18)F]FDG-PET\/CT in pulmonary sarcoidosis. Eur Radiol. 2025;35(4):2222\u201332.","journal-title":"Eur Radiol"},{"issue":"1","key":"4381_CR25","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00259-018-4194-x","volume":"46","author":"M Eskian","year":"2019","unstructured":"Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, et al. Effect of blood glucose level on standardized uptake value (SUV) in (18)F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019;46(1):224\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"13","key":"4381_CR26","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1007\/s00259-021-05307-1","volume":"48","author":"FL Giesel","year":"2021","unstructured":"Giesel FL, Kratochwil C, Schlittenhardt J, Dendl K, Eiber M, Staudinger F, et al. Head-to-head intra-individual comparison of biodistribution and tumor uptake of (68)Ga-FAPI and (18)F-FDG PET\/CT in cancer patients. Eur J Nucl Med Mol Imaging. 2021;48(13):4377\u201385.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"4381_CR27","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1007\/s00330-023-10208-y","volume":"34","author":"K Qiao","year":"2024","unstructured":"Qiao K, Qin X, Fu S, Ren J, Jia J, Hu X, et al. Value of [(18)F]AlF-NOTA-FAPI-04 PET\/CT for differential diagnosis of malignant and various inflammatory lung lesions: comparison with [(18)F]FDG PET\/CT. Eur Radiol. 2024;34(3):1948\u201359.","journal-title":"Eur Radiol"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04381-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04381-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:19:19Z","timestamp":1785518359000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04381-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4381"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04381-1","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"30 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional ethical review board (IRB) of the Peking Union Medical College Hospital (approval number: K4307; approval date: 2023-08-08) and subsequently registered on the Chinese medical research registry (\n                      \n                      ) under ID MR-11-23-041540. The study was conducted in accordance with the Declaration of Helsinki. All prospectively enrolled patients provided written informed consent. Written informed consent from patients in the retrospective\n                      18\n                      F-FDG PET\/CT cohort was waived because we used anonymized health care data, which met the IRB\u2019s minimal risk waiver criteria.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"333"}}